Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002202.SZ Stock Summary
Top 10 Correlated ETFs
002202.SZ
In the News
002202.SZ Financial details
Company Rating
Strong Buy
Market Cap
28.79B
Income
1.29B
Revenue
49.59B
Book val./share
-
Cash/share
-
Dividend
0.12
Dividend %
1.44%
Employees
11.2K
Optionable
No
Shortable
Yes
Earnings
27 Oct 2023
P/E
28.36
Forward P/E
10.01
PEG
-4.34
P/S
0.58
P/B
0.97
P/C
-
P/FCF
-7.37
Quick Ratio
0.69
Current Ratio
1.07
Debt / Equity
1.11
LT Debt / Equity
0.88
-
-
EPS (TTM)
0.3
EPS next Y
0.83
EPS next Q
-
EPS this Y
-38.82%
EPS next Y
181.17%
EPS next 5Y
181.17%
EPS last 5Y
-8.71%
Revenue last 5Y
10.08%
Revenue Q/Q
-23.2%
EPS Q/Q
-
-
-
-
-
SMA20
-5.34%
SMA50
-8.1%
SMA100
-20.91%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
3%
ROC
0.02%
Gross Margin
15%
Oper. Margin
4%
Profit Margin
3%
Payout
160%
Shs Outstand
3.69B
Shs Float
2.68B
-
-
-
-
Target Price
-
52W Range
8.17-11.85
52W High
-24.45%
52W Low
+3.88%
RSI
27.95
Rel Volume
1.56
Avg Volume
15.08M
Volume
23.55M
Perf Week
-5.25%
Perf Month
-5.46%
Perf Quarter
-22.05%
Perf Half Y
-21.46%
-
-
-
-
Beta
0.719
-
-
Volatility
0.15%, 0.26%
Prev Close
0.97%
Price
8.31
Change
-0.36%
002202.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 7.35 | 8.86 | 12.78 | 11.57 | 10.14 | |
Net income per share | 0.82 | 0.51 | 0.67 | 0.79 | 0.52 | |
Operating cash flow per share | 0.8 | 1.37 | 1.22 | 1.12 | 1.28 | |
Free cash flow per share | -0.74 | -1.24 | -0.52 | -1.33 | -0.69 | |
Cash per share | -0.82 | 1.77 | 1.99 | 2.05 | 3.52 | |
Book value per share | 6.39 | 7.11 | 7.76 | 8.13 | 8.32 | |
Tangible book value per share | 5.69 | 6.42 | 6.78 | 6.87 | 7.22 | |
Share holders equity per share | 6.39 | 7.11 | 7.76 | 8.13 | 8.32 | |
Interest debt per share | 5.91 | 5.29 | 6.01 | 7.29 | 8.47 | |
Market cap | 36.37B | 51.58B | 62.73B | 72B | 50.39B | |
Enterprise value | 53.34B | 66.07B | 80.02B | 94.12B | 72.21B | |
P/E ratio | 11.31 | 23.34 | 21.17 | 20.83 | 21.14 | |
Price to sales ratio | 1.27 | 1.35 | 1.11 | 1.42 | 1.09 | |
POCF ratio | 11.64 | 8.7 | 11.67 | 14.73 | 8.57 | |
PFCF ratio | -12.54 | -9.62 | -27.47 | -12.41 | -16.03 | |
P/B Ratio | 1.46 | 1.68 | 1.84 | 2.03 | 1.32 | |
PTB ratio | 1.46 | 1.68 | 1.84 | 2.03 | 1.32 | |
EV to sales | 1.86 | 1.73 | 1.42 | 1.86 | 1.56 | |
Enterprise value over EBITDA | 8.87 | 13.01 | 12.18 | 9.93 | 10.31 | |
EV to operating cash flow | 17.07 | 11.14 | 14.88 | 19.26 | 12.28 | |
EV to free cash flow | -18.39 | -12.33 | -35.04 | -16.22 | -22.97 | |
Earnings yield | 0.09 | 0.04 | 0.05 | 0.05 | 0.05 | |
Free cash flow yield | -0.08 | -0.1 | -0.04 | -0.08 | -0.06 | |
Debt to equity | 0.88 | 0.71 | 0.75 | 0.86 | 0.98 | |
Debt to assets | 0.27 | 0.21 | 0.23 | 0.26 | 0.27 | |
Net debt to EBITDA | 2.82 | 2.85 | 2.63 | 2.33 | 3.11 | |
Current ratio | 1.04 | 0.98 | 0.92 | 0.96 | 1.05 | |
Interest coverage | 3.47 | 3.12 | 5.24 | 6.23 | 3.2 | |
Income quality | 0.95 | 2.66 | 1.81 | 1.4 | 2.41 | |
Dividend Yield | 0.05 | 0.04 | 0.03 | 0.03 | 0.05 | |
Payout ratio | 0.59 | 1.01 | 0.59 | 0.71 | 1.12 | |
Sales general and administrative to revenue | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0.04 | 0.02 | 0.03 | 0.03 | 0.03 | |
Intangibles to total assets | 0.05 | 0.04 | 0.05 | 0.05 | 0.05 | |
Capex to operating cash flow | -1.93 | -1.9 | -1.42 | -2.19 | -1.53 | |
Capex to revenue | -0.21 | -0.3 | -0.14 | -0.21 | -0.19 | |
Capex to depreciation | -4.47 | -7 | -3.91 | -4.59 | -3.29 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 10.88 | 9.05 | 10.84 | 12.03 | 9.87 | |
ROIC | 0.07 | 0.06 | 0.07 | 0.08 | 0.05 | |
Return on tangible assets | 0.04 | 0.02 | 0.03 | 0.03 | 0.02 | |
Graham Net | -10.33 | -8.75 | -9.5 | -10.8 | -10.83 | |
Working capital | 1.32B | -1.12B | -3.81B | -1.95B | 3.24B | |
Tangible asset value | 22.22B | 27.72B | 29.86B | 30.03B | 33.08B | |
Net current asset value | -21.97B | -22.39B | -30.13B | -35B | -34.1B | |
Invested capital | 0.88 | 0.71 | 0.75 | 0.86 | 0.98 | |
Average receivables | 19.53B | 24.39B | 28.02B | 30.02B | 33.43B | |
Average payables | 17.63B | 22.71B | 27.02B | 30.24B | 35.7B | |
Average inventory | 4.54B | 6.56B | 6.92B | 5.27B | 7.33B | |
Days sales outstanding | 258.2 | 271.52 | 179.03 | 234.23 | 270.42 | |
Days payables outstanding | 343.18 | 299.66 | 225.6 | 297.07 | 377.37 | |
Days of inventory on hand | 85.74 | 95.74 | 45.08 | 44.9 | 94 | |
Receivables turnover | 1.41 | 1.34 | 2.04 | 1.56 | 1.35 | |
Payables turnover | 1.06 | 1.22 | 1.62 | 1.23 | 0.97 | |
Inventory turnover | 4.26 | 3.81 | 8.1 | 8.13 | 3.88 | |
ROE | 0.13 | 0.07 | 0.09 | 0.1 | 0.06 | |
Capex per share | -1.54 | -2.62 | -1.74 | -2.45 | -1.97 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.14 | 4.63 | 1.29 | 2.98 | 0 | |
Net income per share | 0.1 | 0.01 | 0.29 | 0 | 0 | |
Operating cash flow per share | 0.1 | 0.01 | 0.29 | -0.12 | 0 | |
Free cash flow per share | -0.36 | -0.72 | -0.01 | -0.46 | 0 | |
Cash per share | 1.2 | 3.68 | 2.48 | 1.59 | 0 | |
Book value per share | 8.57 | 8.7 | 9.11 | 8.62 | 0 | |
Tangible book value per share | 7.08 | 7.56 | 7.89 | 7.47 | 0 | |
Share holders equity per share | 8.57 | 8.7 | 9.11 | 8.62 | 0 | |
Interest debt per share | 8.75 | 8.65 | 8.27 | 8.57 | 0 | |
Market cap | 50.31B | 48.15B | 47.66B | 47.87B | 0 | |
Enterprise value | 83.71B | 69.97B | 72.76B | 75.26B | 27.56B | |
P/E ratio | 28.27 | 360.5 | 9.65 | 721 | 0 | |
Price to sales ratio | 5.3 | 2.37 | 8.57 | 3.56 | 0 | |
POCF ratio | 113.08 | 1.44K | 38.6 | -89.6 | 0 | |
PFCF ratio | -31.35 | -15.27 | -1.74K | -22.94 | 0 | |
P/B Ratio | 1.32 | 1.26 | 1.21 | 1.23 | 0 | |
PTB ratio | 1.32 | 1.26 | 1.21 | 1.23 | 0 | |
EV to sales | 8.81 | 3.45 | 13.08 | 5.6 | 2.67 | |
Enterprise value over EBITDA | 90.07 | 212.7 | 35.93 | 99.43 | 88.11 | |
EV to operating cash flow | 188.15 | 2.1K | 58.93 | -140.87 | 8.23 | |
EV to free cash flow | -52.16 | -22.19 | -2.65K | -36.06 | 20.2 | |
Earnings yield | 0.01 | 0 | 0.03 | 0 | 0 | |
Free cash flow yield | -0.03 | -0.07 | 0 | -0.04 | 0 | |
Debt to equity | 1.01 | 0.98 | 0.9 | 0.99 | 1.11 | |
Debt to assets | 0.3 | 0.27 | 0.27 | 0.28 | 0.29 | |
Net debt to EBITDA | 35.93 | 66.33 | 12.39 | 36.19 | 88.11 | |
Current ratio | 1.02 | 1.05 | 1.08 | 1.11 | 1.07 | |
Interest coverage | 1.92 | -0.32 | 6.16 | 0.4 | 0.52 | |
Income quality | 1 | 1 | 1 | 0 | 0 | |
Dividend Yield | 0.03 | 0.01 | 0.01 | 0.01 | 0 | |
Payout ratio | 3.38 | 12.38 | 0.29 | 22.58 | 97.46 | |
Sales general and administrative to revenue | 0.13 | -0.04 | 0.07 | -0.01 | 0.11 | |
Research and developement to revenue | 0.02 | 0.04 | 0.07 | 0.02 | 0.04 | |
Intangibles to total assets | 0.06 | 0.05 | 0.06 | 0.06 | 0.05 | |
Capex to operating cash flow | -4.61 | -95.44 | -1.02 | 2.91 | -0.59 | |
Capex to revenue | -0.22 | -0.16 | -0.23 | -0.12 | -0.19 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.4 | 1.22 | 7.66 | 0.85 | 0 | |
ROIC | 0.01 | 0 | 0.02 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0.01 | 0 | 0 | |
Graham Net | -11.84 | -11.34 | -11.06 | -12.36 | 0 | |
Working capital | 1.09B | 3.24B | 4.18B | 6B | 4.48B | |
Tangible asset value | 31.4B | 33.08B | 34.06B | 33.68B | 32.73B | |
Net current asset value | -36.65B | -34.1B | -31.17B | -33.47B | -38.32B | |
Invested capital | 1.01 | 0.98 | 0.9 | 0.99 | 1.11 | |
Average receivables | 32.09B | 33.33B | 33.14B | 33.36B | 33.75B | |
Average payables | 30.49B | 35.67B | 35.03B | 32.03B | 35.49B | |
Average inventory | 9.61B | 10.6B | 10.74B | 13.2B | 16.15B | |
Days sales outstanding | 305.56 | 152.73 | 515.4 | 233.46 | 284.77 | |
Days payables outstanding | 369.19 | 197.57 | 660.49 | 261.03 | 399.24 | |
Days of inventory on hand | 131.8 | 49.22 | 251.59 | 115.07 | 186.67 | |
Receivables turnover | 0.29 | 0.59 | 0.17 | 0.39 | 0.32 | |
Payables turnover | 0.24 | 0.46 | 0.14 | 0.34 | 0.23 | |
Inventory turnover | 0.68 | 1.83 | 0.36 | 0.78 | 0.48 | |
ROE | 0.01 | 0 | 0.03 | 0 | 0 | |
Capex per share | -0.46 | -0.73 | -0.29 | -0.34 | 0 |
002202.SZ Frequently Asked Questions
What is Xinjiang Goldwind Science & Technology Co., Ltd. stock symbol ?
Xinjiang Goldwind Science & Technology Co., Ltd. is a CN stock and trading under the symbol 002202.SZ
What is Xinjiang Goldwind Science & Technology Co., Ltd. stock quote today ?
Xinjiang Goldwind Science & Technology Co., Ltd. stock price is $8.31 today.
Is Xinjiang Goldwind Science & Technology Co., Ltd. stock public?
Yes, Xinjiang Goldwind Science & Technology Co., Ltd. is a publicly traded company.